Differential Responses to Acarbose Between Obese and Non-obese Patients with Type 2 Diabetes Mellitus

Author(s):
Chou Chien-WenChou Chien-Wen1, Ou Horng-YihOu Horng-Yih2, Hsiao Shu-HwaHsiao Shu-Hwa2, Wu Ta-JenWu Ta-Jen3
1Division of Endocrinology and Metabolism, Chi-Mei Medical Center, Tainan
2Division of Endocrinology and Metabolism, Department of Internal Medicine, National Cheng Kung University Hospital, Taiwan
3College of Medicine, National Cheng Kung University, *, Taiwan

International Journal of Endocrinology and Metabolism:Vol. 4, issue 2; 63-69
Published online:Apr 30, 2006
Article type:Research Article
Received:Apr 17, 2005
Accepted:Dec 09, 2005
How to Cite:Chien-Wen C, Horng-Yih O, Shu-Hwa H, Ta-Jen W. Differential Responses to Acarbose Between Obese and Non-obese Patients with Type 2 Diabetes Mellitus. Int J Endocrinol Metab. 2006;4(2):. doi:

Abstract

Full Text

Full text is available in PDF

Similar Articles

31
Jan
2008

Effects of Acarbose in Metabolic Control of Patients with Type 1 Diabetes Mellitus

F Sharifi,
M Ghazi Saidi,
N Mousavi Nasab

Sharifi F, Ghazi Saidi M, Mousavi Nasab N. Effects of Acarbose in Metabolic Control of Patients with Type 1 Diabetes Mellitus. Int J Endocrinol Metab. 2008;6(1):. doi:

30
Sep
2013

Comparing the effect of treatment with insulin alone versus insulin plus sulfonylurea in type 2 diabetic patients

S Hashemipou,
S Pourmohammad,
L Ghanei,
N Esmailzadehha,
A Javadi

Hashemipou S, Pourmohammad S, Ghanei L, Esmailzadehha N, Javadi A. Comparing the effect of treatment with insulin alone versus insulin plus sulfonylurea in type 2 diabetic patients. J Inflamm Dis. 2024;17(2):e155751. doi:

31
Jul
2010

Evaluation of abdominal obesity prevalence in diabetic patients and relationships with metabolic syndrome factors

Reza Derakhshan Davari,
Asghar Khoshnood

Derakhshan Davari R, Khoshnood A. Evaluation of abdominal obesity prevalence in diabetic patients and relationships with metabolic syndrome factors. Int J Endocrinol Metab. 2010;8(3):. doi:

21
Apr
2018
Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review

Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review

Hengameh Abdi,
Fereidoun Azizi,
Atieh Amouzegar

Abdi H, Azizi F, Amouzegar A. Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review. Int J Endocrinol Metab. 2018;16(2):e65600. doi: https://doi.org/10.5812/ijem.65600

14
Mar
2005

Outcome of reinitiation of combination anti diabetic oral therapy in insulin treated patients with Type 2 Diabetes Mellitus

M Afkhami-ardekani,
HR Jafaryzadeh

Afkhami-ardekani M, Jafaryzadeh H. Outcome of reinitiation of combination anti diabetic oral therapy in insulin treated patients with Type 2 Diabetes Mellitus. Zahedan J Res Med Sci. 2005;7(1):e94976. doi:

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles